News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Newsfile Corp
NEWS
IN THE PRESS
Press Releases
Biophytis Unveils Its Outlook Strategies for 2025
February 11, 2025
·
4 min read
Press Releases
Medicus Pharma Ltd. Enters into Standby Equity Purchase Agreement and Announces Intention to Voluntarily Delist from the TSX Venture Exchange (TSXV)
February 11, 2025
·
6 min read
Press Releases
Hemostemix Contracts ProConsul to Ramp up Engagement with New Investors
February 10, 2025
·
5 min read
Press Releases
Restart Life Sciences Corp. Relies on Exception Under CSE Policy 4.6(2)(b) for Previously Closed Private Placement and Debt Settlement Transactions and Announces Debt Settlement Transaction
February 7, 2025
·
3 min read
Press Releases
Izotropic Announces Non-Brokered Private Placement
February 7, 2025
·
3 min read
Press Releases
InFlectis BioScience Announces Promising Results for IFB-088 in a Phase 2a Clinical Study in Bulbar-Onset ALS Patients
February 6, 2025
·
3 min read
Press Releases
Izotropic Reschedules Investor Conference Presentation to March 13th
February 6, 2025
·
2 min read
Press Releases
PreveCeutical to Develop Sol-Gel N2B Platform for Parkinson’s Disease
February 6, 2025
·
6 min read
Press Releases
NervGen Completes Dosing of First Subject in Subacute Cohort of its Phase 1b/2a Clinical Trial of NVG-291 in Spinal Cord Injury
February 6, 2025
·
7 min read
Press Releases
Medexus Announces Strong Fiscal Q3 2025 Results, Well-Positioned to Launch GRAFAPEX (treosulfan) for Injection in the United States
February 6, 2025
·
24 min read
15 Toronto St., Suite 601 Toronto ON M5C 2E3 US
Tel: 416-806-1750
Visit website
Email Us